Pilnik Richard D. 4
4 · DiaMedica Therapeutics Inc. · Filed Apr 8, 2025
Insider Transaction Report
Form 4
Pilnik Richard D.
Director
Transactions
- Exercise/Conversion
Voting Common Shares, no par value per share
2025-04-07$2.11/sh+24,000$50,640→ 312,995 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-07−24,000→ 0 totalExercise: $2.11Exp: 2025-12-01→ Voting Common Shares (24,000 underlying)
Footnotes (3)
- [F1]Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025.
- [F2]Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time.
- [F3]This option has fully vested.